Please make JavaScript on and see this site.
December 25, 2024
Review
English Translation of Review Report: Sargmalin
Int
PMDA Updates (December 2024) posted
December 24, 2024
JP
JP 18th Edition Supplement II (English version) posted
Other
Recent Publications by PMDA Staff updated
Drug
Currently, there is no applicable information.
All
Clinical trials, reviews, consultations, compliance assessments, and inspections concerning applications for drugs, medical devices, regenerative medical products, etc.
Collection and provision of information regarding post-marketing safety and scientific research and analyses on data collected.
Relief Systems for Adverse Drug Reactions.
Regulatory science research, the Science Board, projects across multi-offices in PMDA, and standards development (e.g., Japanese Pharmacopoeia, medical device standards).
International harmonization activities such as collaboration with overseas regulatory authorities and international organizations, participation in international meetings including ICH, and activities related to Asia Training Center.
AltStyle によって変換されたページ (->オリジナル) / アドレス: モード: デフォルト 音声ブラウザ ルビ付き 配色反転 文字拡大 モバイル